The Pfizer Clinical Trial and the Road to Success

Late in 2021, the FDA approved the COVID-19 vaccine for children ages 5 to 11 after a historic clinical trial demonstrated it was safe and effective –– a milestone many parents were anxiously awaiting. Children’s Hospital Colorado had the privilege to advance the use of the COVID-19 vaccine by becoming the largest supersite for Pfizer’s clinical trial.

Listen to pediatric experts discuss the COVID-19 vaccine clinical trial

In this episode, Children’s Colorado Chief Quality Officer, Lalit Bajaj, MD, along with Director of Research Operations and Administration, Erin Sandene, and infectious disease expert and professor of pediatrics at the University of Colorado School of Medicine, Eric Simoes, MD, discuss how they paved the way for the Emergency Use Authorization of the Pfizer COVID-19 vaccine for children ages 5 to 11.

In this episode, our experts discuss:

• Why Children’s Colorado was selected as an early participant for Pfizer’s vaccine trial
• How they were able to pull together the resources to enroll 252 patients in under two weeks
• Overcoming the obstacles and challenges of designing such a large, complex study
• The integral contributions of the study participants and their families
• The impact of additional funding to support our child life specialists and other resources
• Important messages for providers regarding the future of COVID-19 and respiratory viruses

Stay up to date with the latest on COVID-19

Experts at Children’s Colorado are committed to maintaining important and timely information for providers during the pandemic. Check back regularly for frequent updates to our COVID-19 resources for healthcare professionals.